Growth Metrics

Aspen Aerogels (ASPN) Equity Average (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Equity Average for 12 consecutive years, with $307.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average fell 40.08% year-over-year to $307.3 million, compared with a TTM value of $307.3 million through Sep 2025, down 40.08%, and an annual FY2024 reading of $551.4 million, up 17.88% over the prior year.
  • Equity Average was $307.3 million for Q3 2025 at Aspen Aerogels, down from $311.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $561.2 million in Q4 2024 and bottomed at $67.2 million in Q1 2021.
  • Average Equity Average over 5 years is $323.8 million, with a median of $314.9 million recorded in 2022.
  • The sharpest move saw Equity Average surged 183.85% in 2023, then tumbled 40.08% in 2025.
  • Year by year, Equity Average stood at $135.4 million in 2021, then surged by 132.53% to $314.9 million in 2022, then soared by 42.55% to $448.9 million in 2023, then rose by 25.0% to $561.2 million in 2024, then tumbled by 45.25% to $307.3 million in 2025.
  • Business Quant data shows Equity Average for ASPN at $307.3 million in Q3 2025, $311.8 million in Q2 2025, and $464.8 million in Q1 2025.